Duopharma Biotech (Malaysia) Today
| 7148 Stock | 1.27 0.01 0.79% |
PerformanceWeak
| Odds Of DistressLow
|
Duopharma Biotech is selling for 1.27 as of the 17th of February 2025. This is a 0.79 percent increase since the beginning of the trading day. The stock's lowest day price was 1.25. Duopharma Biotech has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. The performance scores are derived for the period starting the 19th of November 2024 and ending today, the 17th of February 2025. Click here to learn more.
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Duopharma Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Duopharma Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Duopharma Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Pharmaceuticals, Healthcare, Computing (View all Sectors) |
Duopharma Biotech Bhd (7148) is traded on Kuala Lumpur Exchange in Malaysia . The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.56 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Duopharma Biotech's market, we take the total number of its shares issued and multiply it by Duopharma Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Duopharma Biotech Bhd operates under Healthcare sector and is part of Pharmaceuticals industry.
Duopharma Biotech Bhd has accumulated about 31.5 M in cash with 43.2 M of positive cash flow from operations.
Check Duopharma Biotech Probability Of Bankruptcy
Duopharma Biotech Bhd Risk Profiles
Although Duopharma Biotech's alpha and beta are two of the key measurements used to evaluate Duopharma Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.8596 | |||
| Semi Deviation | 0.9481 | |||
| Standard Deviation | 1.14 | |||
| Variance | 1.3 |
Duopharma Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Duopharma Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Other Information on Investing in Duopharma Stock
Duopharma Biotech financial ratios help investors to determine whether Duopharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Duopharma with respect to the benefits of owning Duopharma Biotech security.